Device Recall Salient Surgical

  • Modelo / Serial
    Devices shipped between July 11, 2008 and July 14, 2011 S/N: TLF05800 TLF06800 TLF07800 TLG13800 TLH14800 TLH15800 TLH23800 TLH28800 TLH24800 TLH12800 TLH13800 TLH30800 TLI05800 TLJ08800 TLJ11800 TLJ21800 TLK05800 PHK06800 PHK08800 PHL01800 PHL03800 PHL04800 PHL05800 PHL06800 PHA30900 PHA3090A PHL0580A PHL0680A PHL0180A PHL0380A PHL0480A PHH14900 ST000590 ST000580 PHH25900 ST000600 ST000610 ST002350 ST002940 PHI30900 PHI17900 PHJ07900 ST000620 ST000630 PHJ19900 PHJ23900 PHK17900 ST000570 ST000640 PHK18900 ST000650 PHK30900 ST000660 PHL01900 PHL08900 PHL14900 PHL21900 PHA07000 ST002550 ST002560 ST003640 ST004260 PHB10000 ST004280 ST004290 ST004300 ST004310 PHA25000 PHB23000 ST004700 ST006570 ST005520 ST005510 ST006580 ST006590 ST006600 ST007570 ST007580 ST007590 ST009260 ST009280 PHD270J0 PHG300F0 ST009670 ST009680 ST010990 PHI130L0 ST011000 ST011010 ST012440 PHK120U0 PHL20000 ST014800 ST014820 ST014810 PHA221A0 ST014830 ST015600 ST015610 PHB18100 PHB241C0 ST016830 ST016840 ST016850 PHB241B0 ST017650 ST017660 ST017670 21113104 21113601 21114302 PHE13100 21116503 PHE31100 21116801 21117201
  • Clasificación del producto
  • Distribución
    Worldwide Distribution - USA (nationwide) and countries of China, Denmark, France, Germany, Greece, Italy, Japan, , South Africa, Spain, and Turkey.
  • Descripción del producto
    Aquamantys 2.3 Bipolar Sealer || Model #23-113-1. || Product Usage: The Aquamantys Bipolar Sealer is a sterile, bipolar electrosurgical device intended to be used in conjunction with the Aquamantys Pump Generator for delivery of RF energy and saline for hemostatic sealing and coagulation of soft tissue and bone at the operative site. It is intended for, but not limited to orthopaedic, spine, thoracic, and open abdominal surgery. The device is not intended for contraceptive tubal coagulation (permanent female sterilization
  • Manufacturer
  • 1 Event

Fabricante

  • Dirección del fabricante
    Salient Surgical Technologies, Inc, 180 International Drive, Portsmouth NH 03801
  • Empresa matriz del fabricante (2017)
  • Comentario del fabricante
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    USFDA